Clinical Trials in New York

Showing 1861-1880 of 22,668 trials

PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

NCT05664477

This is a proof-of-concept phase 2 clinical trial to investigate the safety and effect of the phytoestrogenic supplement PhytoSERM on regional brain metabolism by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in peri- and postmenopausal women. The investigators hypothesize that there will be a significant difference between the PhytoSERM group and placebo group in glucose brain metabolism.

MenopauseCognitive ChangeBrain Disorder, Metabolic

Roberta Brinton100 participantsStarted Jan 2024

Tucson, Arizona, United States • New York, New York, United States

Active Not RecruitingPhase 2< 1 mile

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

NCT06550895

The purpose of this study is to define the safety of Ciltacabtagene Autoleucel (Cilta-cel) and Talquetamab in participants with high-risk multiple myeloma (MM).

Multiple Myeloma

Janssen Research & Development, LLC11 participantsStarted Sep 2024

Iowa City, Iowa, United States • Louisville, Kentucky, United States • Detroit, Michigan, United States +6 more locations

PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

Find Trials by Condition in New York

A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

TITAN™ Reverse Shoulder System

A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease